Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol. 2020;95(12):1578–89.

Article  CAS  Google Scholar 

Schwartzbard AZ, Tunick PA, Rosenzweig BP, Kronzon I. The role of transesophageal echocardiography in the diagnosis and treatment of right atrial thrombi. J Am Soc Echocardiogr. 1999;12(1):64–9.

Article  CAS  Google Scholar 

Egolum UO, Stover DG, Lenihan D, Damp JB, Anthony R, Wasserman AM. Intracardiac thrombus: diagnosis, complications and management. Am J Med Sci. 2013;345(5):391–5.

Article  Google Scholar 

Sokmen G, Sokmen A, Altun B. Free floating right atrial thrombus leading to acute pulmonary embolism. Int J Cardiol. 2008;129(1):e12–4.

Article  Google Scholar 

Acherjee T, Behara A, Saad M, Vittorio TJ. Mechanisms and management of prothrombotic state in COVID-19 disease. Ther Adv Cardiovasc Dis. 2021;15:17539447211053470.

Article  CAS  Google Scholar 

Charif F, Mansour MJ, Hamdan R, Najjar C, Nassar P, Issa M, et al. Free-floating right heart thrombus with acute massive pulmonary embolism: a case report and review of the literature. J Cardiovas Echogr. 2018;28(2):146.

Article  Google Scholar 

Rose PS, Punjabi NM, Pearse DB. Treatment of right heart thromboemboli. Chest. 2002;121(3):806–14.

Article  Google Scholar 

Dalen JE. Free-floating right heart thrombi. Am J Med. 2017;130(5):501.

Article  Google Scholar 

Anthi A, Konstantonis D, Theodorakopoulou M, Apostolopoulou O, Karampela I, Konstantopoulou G, et al. A severe covid-19 case complicated by right atrium thrombus. Am J Case Rep. 2020;21:e926915–21.

Article  Google Scholar 

Deana C, Vetrugno L, Fabris M, Curcio F, Sozio E, Tascini C, et al. Pericardial cytokine “storm” in a COVID-19 patient: the confirmation of a hypothesis. Inflammation. 2022;45(1):1–5.

Article  CAS  Google Scholar 

Dzudovic B, Obradovic S, Rusovic S, Gligic B, Rafajlovski S, Romanovic R, et al. Therapeutic approach in patients with a floating thrombus in the right heart. J Emerg Med. 2013;44(2):e199–205.

Article  Google Scholar 

Huang SL, Chien CH, Chang YC. A floating thrombus of the right ventricle in severe massive pulmonary embolism. Am J Emerg Med. 2008;26(9):1071. e1-e2.

Article  Google Scholar 

Chartier L, Béra J, Delomez M, Asseman P, Beregi J-P, Bauchart J-J, et al. Free-floating thrombi in the right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation. 1999;99(21):2779–83.

Article  CAS  Google Scholar 

Califf RM, Fortin DF, Tenaglia AN, Sane DC. Clinical risks of thrombolytic therapy. Am J Cardiol. 1992;69(2):A12–20.

Article  Google Scholar 

Deana C, Verriello L, Pauletto G, Corradi F, Forfori F, Cammarota G, et al. Insights into neurological dysfunction of critically ill COVID-19 patients. Trends Anaesth Crit Care. 2021;36:30–8.

Article  Google Scholar 

Özkan M, Gündüz S, Gürsoy OM, Karakoyun S, Astarcıoğlu MA, Kalçık M, et al. Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial. Am Heart J. 2015;170(2):409-18. e1.

Article  Google Scholar 

Biteker M, Duran NfE, Gündüz S, Kaya H, Kaynak E, Çevik C, et al. Comparing different intravenous thrombolytic treatment regimens in patients with prosthetic heart valve thrombosis under the guidance of serial transesophageal echocardiography: a 15-year study in a single center (TROIA Trial). Circulation. 2008;118:S_932.

Güneş Y, Ceylan Y, Tuncer M. Successful lysis of a mobile left ventricular thrombus by slow infusion of low-dose tissue plasminogen activator. Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir. 2010;38(7):489–91.

Google Scholar 

Akcay M, Soylu K, Yanik A. Acute thrombotic left main coronary artery; treatment with low dose slow infusion tPA. Int J Cardiol. 2016;224:265–6.

Article  Google Scholar 

Aykan AÇ, Boyaci F, Hatem E. Successful treatment of a pulmonary embolism with low dose prolonged infusion of tissue typed plasminogen activator in a 37 year old female in early postoperative period. Anadulu Kardiyoloji Dergisi: AKD. 2014;14(4):400.

Article  Google Scholar 

Kalkan ME, Yildiz M, Ak HY, Agus HZ, Ozsahin Y, Aykan AC, et al. Safety of low-dose prolonged infusion of tissue plasminogen activator therapy in patients with thromboembolic events in the intensive care unit. Kardiologiia. 2020;60(7):86–90.

Article  Google Scholar 

Karakurt A. New Thrombolytic Infusion Application of Dissolving Renal Artery Embolic Thrombosis: Low-Dose Slow-Infusion Thrombolytic Therapy. Case Rep Nephrol. 2018;2018:1609025.

Google Scholar 

Alves Pinto R, Torres S, Formigo M, Resende C, Proenca T, Carvalho J, et al. 1115 Ultra-slow low-dose thrombolytic therapy as an option of treatment in intracardiac thrombus: a case report. Eur Heart J Cardiovas Imaging. 2020;21(231):319–660.

Google Scholar 

Yılmaztepe M. Slow Infusion Thrombolytic Therapy for Massive Pulmonary Embolism With Intracardiac Thrombus. Am J Cardiol. 2018;121(8):e127–8.

Article  Google Scholar